---
title: "PBLA.US (PBLA.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/PBLA.US/news.md"
symbol: "PBLA.US"
name: "PBLA.US"
parent: "https://longbridge.com/en/quote/PBLA.US.md"
datetime: "2026-03-14T08:41:02.343Z"
locales:
  - [en](https://longbridge.com/en/quote/PBLA.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PBLA.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PBLA.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/PBLA.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/PBLA.US/news.md)


# PBLA.US (PBLA.US) — Related News

### [Cassava Sciences Rebrands as Filana Therapeutics, Updates Ticker](https://longbridge.com/en/news/278559807.md)
*2026-03-10T12:49:09.000Z*
> Cassava Sciences Rebrands as Filana Therapeutics, Updates Ticker

### [Panbela reports Q3 2024 financial results, including $12M secured financing and progress in clinical programs. Net loss of $7.2M with cash at $142K.](https://longbridge.com/en/news/219731133.md)
*2024-11-14T21:32:09.000Z*
> Panbela Therapeutics reported Q3 2024 financial results, showing a net loss of approximately $0.2 million. The company s

### [Panbela to hold Q3 earnings conference call on Nov 14, 2024 at 4:30 PM Eastern Time.](https://longbridge.com/en/news/218474246.md)
*2024-10-31T12:26:40.000Z*
> A biopharmaceutical company, Panbela Therapeutics, Inc. (OTCQB: PBLA), has disclosed plans to hold a conference call on 

### [Panbela Provides Business Update and Reports Q2 2024 Financial Results](https://longbridge.com/en/news/211488112.md)
*2024-08-13T20:40:04.000Z*
> Panbela Therapeutics, Inc. provides a business update and reports Q2 2024 financial results. The company highlights clin

### [Panbela to Host Second Quarter 2024 Earnings Conference Call on Aug 13, 2024](https://longbridge.com/en/news/210249566.md)
*2024-07-30T21:21:56.000Z*
> MINNEAPOLIS, July 30, 2024 ( GLOBE NEWSWIRE ) -- Panbela Therapeutics, Inc.

### [Panbela Provides Business Update and Reports Q1 2024 Financial Results](https://longbridge.com/en/news/204185470.md)
*2024-05-15T20:13:22.000Z*
> Panbela Therapeutics, a clinical stage company, provides a business update and reports Q1 2024 financial results. Highli

### [Panbela Announces Transfer to OTCQB Market](https://longbridge.com/en/news/202104853.md)
*2024-04-16T21:31:01.000Z*
> Panbela Therapeutics, Inc. has announced that its common stock will be quoted on the OTCQB market starting April 17, 202

### [Roth MKM Maintains Buy on Panbela Therapeutics, Maintains $25 Price Target](https://longbridge.com/en/news/200804723.md)
*2024-03-27T15:59:18.000Z*
> Roth MKM analyst Jonathan Aschoff maintains Panbela Therapeutics (OTC:PBLA) with a Buy and maintains $25 price target.